Abstract
Extracorporeal membrane oxygenation (ECMO) is a life-sustaining therapy that has been used as a means of rescue treatment for severe hypoxemia. Survival benefit has also been demonstrated with the use of ECMO for ARDS related to other viral infections, and the use of veno-venous ECMO is recommended for COVID-19-associated respiratory failure by organizations including the Extracorporeal Life Support Organization (ELSO), the World Health Organization (WHO), and the Surviving Sepsis Campaign COVID-19 panel. In general, ECMO can afford time to allow other treatments to take effect. Transfer to an ECMO center should be considered when the morbidity and mortality of the underlying conditions outweigh the anticipated morbidity or mortality associated with ECMO.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Brogan TV. Extracorporeal Life Support Organization – Extracorporeal Life Support: the ELSO red book 5th edition [Internet]. 5th ed. Ann Arbor: Extracorporeal Life Support Organization; 2017. [cited 2020 Nov 14]. Available from: https://www.elso.org/Publications/RedBook5thEdition.aspx.
Sangalli F, Patroniti N, Pesenti A, editors. ECMO-Extracorporeal Life Support in adults [Internet]. Mailand: Springer-Verlag; 2014. [cited 2021 Feb 27]. Available from: https://www.springer.com/gp/book/9788847054264.
Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351–63.
Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378(21):1965–75.
Sanford Z, Madathil RJ, Deatrick KB, Tabatabai A, Menaker J, Galvagno SM, et al. Extracorporeal membrane oxygenation for COVID-19. Innovations. 2020;15(4):306–13.
Schmidt M, Hajage D, Lebreton G, Monsel A, Voiriot G, Levy D, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. Lancet Respir Med. 2020;8(11):1121–31.
Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;28:1–34.
Shekar K, Badulak J, Peek G, Boeken U, Dalton HJ, Arora L, et al. Extracorporeal Life Support Organization Coronavirus Disease 2019 interim guidelines: a consensus document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers. ASAIO J. 2020;66(7):707–21.
Extracorporeal Life Support Organization – ECMO and ECLS > Registry > Full COVID-19 Registry Dashboard [Internet]. [cited 2020 Sep 12]. Available from: https://www.elso.org/Registry/FullCOVID19RegistryDashboard.aspx.
Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020;396(10257):1071–8.
Shao F, Xu S, Ma X, Xu Z, Lyu J, Ng M, et al. In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation. 2020;151:18–23.
Ferrari M, Santini A, Protti A, Andreis DT, Iapichino G, Castellani G, et al. Inhaled nitric oxide in mechanically ventilated patients with COVID-19. J Crit Care. 2020;60:159–60.
Kandori K, Narumiya H, Iizuka R. Extracorporeal cardiopulmonary resuscitation should not be performed on confirmed or suspected COVID-19 patients. Resuscitation. 2020;153:6–7.
Coronavirus disease (COVID-19) – World Health Organization [Internet]. [cited 2020 Sep 6]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
Hanidziar D, Bittner EA. Sedation of mechanically ventilated COVID-19 patients: challenges and special considerations. Anesth Analg [Internet]. 2020; [cited 2021 Feb 27]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179055/.
Garcia B, Cousin N, Bourel C, Jourdain M, Poissy J, Duburcq T, et al. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome. Crit Care. 2020;24(1):428.
Alvarez RA, Berra L, Gladwin MT. Home nitric oxide therapy for COVID-19. Am J Respir Crit Care Med. 2020;202(1):16–20.
Imamura T, Nikhil N. Optimal therapeutic strategy using extracorporeal membrane oxygenation in patients with COVID-19. J Card Surg. 2020;35(10):2872–3.
White D, MacDonald S, Bull T, Hayman M, de Monteverde-Robb R, Sapsford D, et al. Heparin resistance in COVID-19 patients in the intensive care unit. J Thromb Thrombolysis. 2020;50(2):287–91.
Seelhammer TG, Rowse P, Yalamuri S. Bivalirudin for maintenance anticoagulation during venovenous extracorporeal membrane oxygenation for COVID-19. J Cardiothorac Vasc Anesth. 2021;35(4):1149–53.
Usman AA, Han J, Acker A, Olia SE, Bermudez C, Cucchiara B, et al. A case series of devastating intracranial hemorrhage during venovenous extracorporeal membrane oxygenation for COVID-19. J Cardiothorac Vasc Anesth. 2020;34(11):3006–12.
Masur J, Freeman CW, Mohan S. A double-edged sword: neurologic complications and mortality in extracorporeal membrane oxygenation therapy for COVID-19–related severe acute respiratory distress syndrome at a tertiary care center. Am J Neuroradiol. 2020;41(11):2009–11.
Heman-Ackah SM, Su YS, Spadola M, Petrov D, Chen HI, Schuster J, et al. Neurologically devastating intraparenchymal hemorrhage in COVID-19 patients on extracorporeal membrane oxygenation: a case series. Neurosurgery. 2020;87(2):E147–51.
LoSavio PS, Patel T, Urban MJ, Tajudeen B, Papagiannopoulos P, Revenaugh PC, et al. Management of upper airway bleeding in COVID-19 patients on extracorporeal membrane oxygenation. Laryngoscope. 2020;130(11):2558–60.
Lemmers DHL, Hilal MA, Bnà C, Prezioso C, Cavallo E, Nencini N, et al. Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty? ERJ Open Res [Internet]. 2020 [cited 2021 Feb 27];6(4). Available from: https://openres.ersjournals.com/content/6/4/00385-2020.
McGuinness G, Zhan C, Rosenberg N, Azour L, Wickstrom M, Mason DM, et al. High incidence of barotrauma in patients with COVID-19 infection on invasive mechanical ventilation. Radiology [Internet]. 2020 [cited 2021 Feb 27]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336751/.
Mustafa AK, Alexander PJ, Joshi DJ, Tabachnick DR, Cross CA, Pappas PS, et al. Extracorporeal membrane oxygenation for patients with COVID-19 in severe respiratory failure. JAMA Surg. 2020;155(10):990.
Fernando SM, Mathew R, Slutsky AS, Rochwerg B, Kyeremanteng K, Combes A, et al. Media portrayals of outcomes after extracorporeal membrane oxygenation. JAMA Intern Med [Internet]. 2021; [cited 2021 Jan 13]; Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2774726.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ball, E., Azevedo, K., Marinaro, J. (2021). ECMO and Rescue Therapies for Severe Hypoxemia. In: Shiber, J.R. (eds) Critical Care of COVID-19 in the Emergency Department. Springer, Cham. https://doi.org/10.1007/978-3-030-85636-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-85636-6_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-85635-9
Online ISBN: 978-3-030-85636-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)